Scynexis Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Due Diligence for Asset Managers
You have viewed 10 of the 10 daily limit
Subscribe for $29/month to gain full access
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Scynexis Inc
TickerSCYX
CIK #0001178253
CUSIP811292200
SectorLife Sciences - Pharmaceutical Preparations
Address3501-C Tricenter Blvd, Durham, NC 27713
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Scynexis Inc 2011-12-16 11.4 M Exemption: 506 · Remaining: $3,558,157 · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001178253] 10-K
[0001178253] 10-Q
[0001178253] 3
[0001178253] 4
[0001178253] 8-K
[0001178253] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
CVI Investments Inc Scynexis Inc [2026-04-28] 0.0
Squadron Capital Management LLC Scynexis Inc [2026-04-08] 0.0
Great Point Partners LLC Scynexis Inc [2026-04-07] 0.0
Stonepine Capital Management LLC Scynexis Inc [2023-06-09] 7.6
Kingdon Capital Management LLC Scynexis Inc [2023-04-13] 5.1
Hirschman Orin Scynexis Inc [2021-06-10] 6.5
Perceptive Advisors LLC Scynexis Inc [2021-01-27] 6.8
Avidity Partners Management LP Scynexis Inc [2020-12-23] 0.9
Stonepine Capital Management LLC Scynexis Inc [2020-12-23] 7.7
Decheng Capital China Life Sciences USD Fund III LP Scynexis Inc [2019-12-23] 5.8
Armistice Capital LLC Scynexis Inc [2019-12-20] 5.7
Puissance Life Science Opportunities Fund VI Scynexis Inc [2019-03-15] 0.99
Stonepine Capital Management LLC Scynexis Inc [2018-10-25] 6.1
Caxton Corp Scynexis Inc [2018-03-13] 0.99
Federated Investors Inc /PA/ Scynexis Inc [2016-02-11] 8.87
Broadfin Capital LLC Scynexis Inc [2015-05-27] 5.6
FMR LLC Scynexis Inc [2015-05-11] 0.0
Foresite Capital Fund II LP Scynexis Inc [2015-02-11] 7.8
GlaxoSmithKline PLC Scynexis Inc [2014-05-15] 6.2
Alta Biopharma Partners II LP Scynexis Inc [2014-05-14] 14.7
Sanofi Scynexis Inc [2014-05-09] 19.27
Flynn James E Scynexis Inc [2014-05-09] 9.0
RA Capital Management LLC Scynexis Inc [2014-05-08] 0.9
Form 3/4/5 Filer 2011 - 2026
Scynexis Inc
Hanham Ann
Tinmouth Brian Philippe
Macdonald Guy
Anido Armando
Hastings David C
Angulo Gonzalez David
Sukenick Scott
Macleod ivor
Gilman Steven C
Taglietti Marco
Coyne Christine
Hoffman Lawrence R
Francois Eric
Perceptive Life Sciences Master Fund Ltd
Edelman Joseph
Perceptive Advisors LLC
Machado Patrick
McCourt Marion
Langlois Patrick
Woodall Jonathan Sears
Ribeill Yves J
Penhoet Edward
Nothias Jean-Yves
Kirby Pamela J
Osborne Jr Charles F
Sable Carole
Pruette Eileen
Arthaud Laurent
Chaoui Mounia
Sanofi
FCPR Genavent
FCPR Biotechnology Fund
Ventech Capital II
Champsi Farah
Alta Biopharma Management II LLC
Alta Biopharma Partners II LP
Alta Embarcadero Biopharma Partners II LLC
Doelling Vivian W
Garrett Michael C
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Angulo Gonzalez David
Common Stock
2026-01-29 Grant 391,333 $0.00
Sukenick Scott
Common Stock
2026-01-29 Grant 129,833 $0.00
Macleod ivor
Common Stock
2026-01-29 Grant 129,833 $0.00
Angulo Gonzalez David
Common Stock
2025-10-17 Grant 32,500 $0.76 24,700
Macdonald Guy
Common Stock
2025-06-26 Grant 23,000 $0.00
Anido Armando
Common Stock
2025-06-26 Grant 23,000 $0.00
Gilman Steven C
Stock Option · derivative
2025-06-26 Grant 23,000 $0.00
Tinmouth Brian Philippe
Stock Option · derivative
2025-06-26 Grant 23,000 $0.00
Hanham Ann
Stock Option · derivative
2025-06-26 Grant 23,000 $0.00
Hastings David C
Common Stock
2025-06-26 Grant 23,000 $0.00
Hastings David C
Stock Option · derivative
2025-06-26 Grant 23,000 $0.00
Hanham Ann
Common Stock
2025-06-26 Grant 23,000 $0.00
Macdonald Guy
Stock Option · derivative
2025-06-26 Grant 23,000 $0.00
Tinmouth Brian Philippe
Common Stock
2025-06-26 Grant 23,000 $0.00
Gilman Steven C
Common stock
2025-06-26 Grant 23,000 $0.00
Anido Armando
Stock Option · derivative
2025-06-26 Grant 23,000 $0.00
Angulo Gonzalez David
Common Stock
2025-04-09 Grant 23,000 $0.84 19,320
Angulo Gonzalez David
Common Stock
2025-03-20 Grant 13,800 $1.05 14,490
Angulo Gonzalez David
Common Stock
2025-03-19 Grant 5,000 $1.07 5,350
Macleod ivor
Common Stock
2025-01-23 Grant 92,511 $0.00
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 46 31,938,157
2025-12-31 38 8,660,437
2025-09-30 43 11,771,641
2025-06-30 41 11,104,837
2025-03-31 42 11,609,661
2024-12-31 50 12,093,977
2024-09-30 47 13,188,144
2024-06-30 58 13,941,118
2024-03-31 58 14,958,574
2023-12-31 55 18,779,180
2023-09-30 63 16,714,167
2023-06-30 57 17,570,946
Form 13F Holdings
Firm Period DFND Voting Shares
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com